Search CommunityWalk:


Otsuka America Pharmaceutical Inc

2440 Research Boulevard
Rockville, MD 20850, USA

Category: Healthcare Facilities & Services

Used in the following map:

Maryland Biotech Industry Map

Otsuka America Pharmaceutical Inc (OAPI) is a healthcare company, with a strong focus and commitment to neuroscience, oncology and hospital therapies. It was established in 1989. The company is part of the Otsuka Group ("Otsuka").

Otsuka America has commercialized a diversified portfolio of products for use in the following therapeutic categories: Schizophrenia, Bipolar Disorder, Adjunctive Therapy for Major Depressive Disorder, Conditioning agent prior to allogeneic hematopoietic stem cell transplantation in CML, Clinically Significant Hypervolemic and Euvolemic Hyponatremia, Intermittent Claudication, and Detection of H. Pylori. Its product portfolio includes: ABILIFY® (aripiprazole) Tablets, SAMSCA® (tolvaptan), IV BUSULFEX® (busulfan) Injection, BreathTek®, Urea Breath® Test (UBT) for H.pylori Kits, PLETAL® (cilostazol) Tablets, etc. The company's product portfolio is focused primarily in the areas of neuroscience, oncology, and hospital therapies.

Otsuka America has agreements with Xceleron Ltd, Sacred Heart Medical Center & Children's Hospital, Summit Corporate Services, Inc., Prasco Laboratories, etc.